Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol with traumatic memory reactivation for pediatric PTSD
2020-005956-39Phase 3Completed
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in post-traumatic stress disorder (PTSD) comparing Propranolol + traumatic memory reactivation with Placebo + traumatic memory reactivation (2 arms). Started Jan 2021; status: completed.
02
Drugs
propranolol
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on 2020-005956-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-005956-39.